Cellular senescence is a recognized mechanism of tumour suppression; however, its contribution to other pathologies is not well understood. We show that the matricellular protein CCN1 (also known as CYR61; cysteine-rich protein 61), which is dynamically expressed at sites of wound repair, can induce fibroblast senescence by binding to integrin α 6 β 1 and the heparan sulphate proteoglycans (receptors involved in cell adhesion). CCN1 induces DNA damage response pathways and activates p53 and the RAC1-NOX1 complex, which generates reactive oxygen species (ROS). This results in the ROS-dependent activation of the p16 INK4a /pRb pathway, leading to senescence and concomitant expression of antifibrotic genes. Senescent fibroblasts accumulate in granulation tissues of healing cutaneous wounds and express antifibrotic genes in wild-type mice. These processes are lost in knockin mice that express a senescence-defective Ccn1 mutant, resulting in exacerbated fibrosis. Topical application of CCN1 protein to wounds reverses these defects. Thus, fibroblast senescence is a CCN1-dependent wound healing response in cutaneous injury that functions to curb fibrosis during tissue repair.
Originally characterized in human fibroblasts experiencing replicative exhaustion in culture 1 , cellular senescence is an essentially irreversible form of cell-cycle arrest that can be triggered by a variety of cellular damages or stresses, including DNA damage, oncogene activation, oxidative stress and telomere erosion 2, 3 . Senescent cells remain viable and metabolically active, but are unable to proliferate despite the presence of nutrients and mitogens. Recent studies have established that cellular senescence is an important mechanism of tumour suppression, which functions by blocking the proliferation of damaged cells at risk of neoplastic transformation [4] [5] [6] . Senescent cells are also found in various noncancerous pathologies and aged tissues, although their roles in these contexts have not been thoroughly explored.
In addition to cell-cycle arrest, senescent cells exhibit an enlarged and flattened cell morphology, accumulate senescence-associated β-galactosidase (SA-β-gal) and upregulate a number of secreted proteins that comprise the senescence-associated secretory phenotype (SASP) or the senescence messaging secretome (SMS) 2, 7, 8 . Proteins secreted by senescent cells include pro-inflammatory cytokines, growth regulatory factors and participants in extracellular matrix (ECM) metabolism. Some of these secreted proteins, including interleukin-6 (IL-6), chemokine receptor 2 ligands, insulin-like growth factor-binding proteins and plasminogen activator inhibitor-1, can reinforce or exacerbate senescence [9] [10] [11] [12] [13] . Although senescence can suppress tumorigenesis, some of the proteins secreted by senescent cells may paradoxically promote the malignant phenotypes of neighbouring cells and disrupt the integrity and function of normal tissues 14 , suggesting that the SASP/SMS may have diverse and context-dependent roles in tissue pathologies. Recent studies showed that senescent hepatic stellate cells accumulate in carbon tetrachloride (CCl 4 )-induced liver damage and dampen liver fibrosis through the expression of antifibrotic proteins 15 . These results suggest that senescent cells may arise to limit fibrosis during tissue repair, although this possibility has not been examined beyond CCl 4 -induced liver injury [15] [16] [17] .
Among the proteins whose expression is associated with wound repair is the matricellular protein CCN1, which regulates diverse cellular functions, including cell adhesion, migration, differentiation and survival in a cell-type-and context-dependent manner 18 . CCN1 is a potent inducer of angiogenesis and Ccn1-null mice are embryonic lethal, owing to defects in cardiovascular development [19] [20] [21] . Here we show that CCN1, which is highly expressed in granulation tissues during cutaneous wound healing 22 , drives fibroblasts into senescence and upregulates the expression of antifibrotic genes to restrict fibrosis during tissue repair. These findings uncover a pathway of senescence induction through integrin-mediated cell adhesion, and further establish senescence as a mechanism for controlling fibrogenesis in wound healing.
RESULTS

Accumulation of senescent cells in the granulation tissue of healing wounds requires CCN1
Cutaneous wound healing occurs in three overlapping phases: it starts with an inflammatory phase marked by infiltration of neutrophils and macrophages, followed by a proliferative phase that includes ECM deposition and ends with a maturation phase that brings about matrix remodelling and resolution of the granulation tissue ( Fig. 1a) 23, 24 . The functions of CCN1 in fibroblasts are largely mediated through its direct binding to integrin α 6 β 1 and cell-surface heparan sulphate proteoglycans (HSPGs) [25] [26] [27] [28] [29] , whereas its angiogenic activities are mediated through integrin α v β 3 (ref. 30) . As Ccn1-null mice are embryonic lethal, to investigate the role of CCN1 in wound healing we used knockin mice (Ccn1 dm/dm ) in which the Ccn1 genomic locus is replaced by an allele encoding DM, a CCN1 mutant with the α 6 β 1 integrin-HSPG binding sites disrupted by alanine substitutions 28 . Comparable levels of CCN1 protein were detected in fullthickness excisional wounds of wild-type (WT; Ccn1 WT/WT ) and Ccn1 dm/dm mice, accumulating 5-9 days post-wounding 22 (Supplementary information, Fig. S1a ). Although wounds of both genotypes healed completely by day 13, wound closure occurred with faster kinetics in Ccn1 dm/dm mice ( Fig. 1b ). Consistent with faster healing, granulation tissue of Ccn1 dm/ dm mice showed a higher percentage of Ki-67-positive proliferating cells than wild-type mice, whereas the numbers of apoptotic cells were essentially identical ( Fig. 1c, d) . These results indicate that proportionately more cells in wounds of wild-type mice were driven out of the cell cycle in an apoptosis-independent manner, suggesting that some of these cells might be undergoing senescence.
Remarkably, granulation tissues of wild-type mice accumulated senescent cells most significantly between 7-9 days post-wounding when CCN1 expression peaked, as judged by SA-β-gal activity ( Fig. 1e and Supplementary information, Fig. S1b ). Although senescent cells have been isolated from human patients with chronic non-healing wounds 31, 32 , to our knowledge they have not been previously reported in models of normal cutaneous wounds. SA-β-gal-positive cells were virtually abolished in granulation tissue of Ccn1 dm/dm mice, indicating that CCN1 is critical for the establishment or maintenance of cellular senescence ( Fig. 1e ). Furthermore, the senescence markers p16 INK4a and p53 were detected in the wounds of wild-type, but not in Ccn1 dm/dm mice ( Fig. 1f ; Supplementary information, Fig. S1c ). Cells staining positive for p16 INK4a or p53 were also positive for α-smooth muscle actin (α-SMA), indicating that the senescent cells were myofibroblasts. To verify these results, fibroblasts were isolated from 7-and 9-day wounds and plated in tissue culture dishes; approxi-mately11-15% of cells from wounds of wild-type mice were SA-β-galpositive, compared with approximately 3% from Ccn1 dm/dm mice (Fig. 1g ). These results show that CCN1, through its α 6 β 1 integrin-HSPG binding sites, is required for the accumulation of senescent fibroblasts in granulation tissue during cutaneous wound healing.
CCN1 induces senescence in human fibroblasts through integrin signalling
To test whether CCN1 can directly induce cellular senescence, we treated young human BJ skin fibroblasts cultured in 10% serum with purified recombinant CCN1 protein. We found that CCN1 induced premature senescence as judged by several criteria. First, application of CCN1 arrested cell proliferation within 3 days, as shown by stagnant cell numbers and >50% decrease in 5-bromodeoxyuridine (BrdU) incorporation and Ki-67-positive cells when compared with bovine nature cell biology VOLUME 12 | NUMBER 7 | JULY 2010 6 7 7 serum albumin (BSA)-treated controls ( Fig. 2a -c), whereas no apoptosis was observed with or without CCN1 (data not shown). CCN1 inhibited cell proliferation in a dose-dependent manner that was detectable at 250 ng ml -1 and maximal at 5 μg ml -1 (Supplementary information, Fig. S2a ). Second, CCN1-induced growth arrest was irreversible once established, even after CCN1 was removed. Cells treated with CCN1 for 6 days to establish senescence were harvested by trypsinization and replated in fresh medium to remove extracellular CCN1. The replated cells did not divide further, even after six more days of culture in the absence of CCN1 ( Fig. 2d ). Third, CCN1-treated fibroblasts exhibited an enlarged and flattened cell morphology characteristic of senescent cells ( Fig. 2e ), and fourth, these cells expressed markers of senescence including SA-β-gal, p53 and p16 INK4a (Fig. 2f-h) . Consistent with the SASP/SMS, CCN1-treated cells upregulated the expression of several proinflammatory cytokines (IL-6, IL-8 and IL-11) and matrix-degrading enzymes (MMP1 and MMP3), and significantly downregulated expression of type I collagen (COL1Α1; Fig. 2i -k). CCN1 also induced senescence phenotypes in IMR-90 human diploid lung fibroblasts, indicating that this response is not limited to BJ cells (Supplementary information, Fig. S2b , c).
As CCN1 is an ECM protein that supports cell adhesion, we tested its activity as a cell-adhesion substrate. BJ cells expressed SA-β-gal when plated on immobilized CCN1, but not on fibronectin, laminin or vitronectin ( Fig. 3a) , indicating that CCN1 can induce senescence as a cell-adhesion substrate and that this activity is unique among the ECM proteins tested. Consistent with impaired senescence in Ccn1 dm/dm mice, purified DM protein 26 was unable to inhibit DNA synthesis, induce SA-β-gal expression or trigger the SASP/SMS ( Fig. 3b-d ; Supplementary information, Fig. S2e ). By contrast, D125A (ref. 30 ), a single amino-acid substitution CCN1 mutant defective for binding α v integrins, could still induce senescence ( Fig. 3b-d ). Pretreatment of cells with either soluble heparin or a function-blocking monoclonal antibody against α 6 integrin inhibited CCN1-induced SA-β-gal expression, whereas an antibody against α v β 3 integrin had no effect, indicating the involvement of α 6 β 1 integrin and HSPGs (Fig. 3e, f ). Furthermore, the addition of a peptide that competitively binds α 6 β 1 integrin specifically (T1; ref. 33 ) blocked CCN1-induced senescence, whereas a peptide with a two-residue substitution (T1-mut) that abrogated binding of α 6 β 1 integrin was ineffective ( Fig. 3g ). These results indicate that CCN1 induces senescence through an integrin-mediated mechanism involving α 6 β 1 integrin and HSPGs. 
CCN1-induced senescence requires p53 and p16 INK4a
Cellular responses to known senescence-inducing signals are established and maintained by either the p53 and/or p16 INK4a /pRb tumour suppressor pathways, depending on the cell type and context 2, 3 . Both p53 and p16 INK4a proteins accumulated on CCN1 treatment, indicating their activation ( Fig. 4a ). It is known that DNA damage response pathways, induced by double strand breaks or uncapped telomeres, can result in activation of ATM (ataxia telangiectasia mutated) and Chk2; phosphorylation of p53 at Ser 20 by Chk1 or Chk2 stabilizes p53 by dissociating it from HDM2/Mdm2 (refs 34, 35) . CCN1 induced phosphorylation of ATM, Chk1 and Chk2, and concomitantly, phosphorylation of p53 on Ser 20 ( Fig. 4b ) indicating that CCN1 activates DNA damage response pathways and p53. Other forms of cellular stress, including ROS, can also activate p53 (ref. 36 ). CCN1-mediated activation of p53 was partially inhibited by the ROS scavenger N-acetyl cysteine (NAC), indicating that CCN1 activates p53 in part through a ROSdependent pathway ( Supplementary Information, Fig. S3a ). The induction of p16 INK4a on treatment with CCN1 was accompanied by the activation of pRb , as judged by its hypophosphorylation. p16 INK4a can activate pRb independently of p53 by inhibiting Cdk4 and Cdk6. To investigate the function of p53, we expressed short-hairpin RNAs (shRNAs) to silence its expression. Complete p53 knockdown using two different shRNA sequences (shp53#1 and #3) restored cell proliferation by approximately 80%, whereas a partial knockdown (shp53#2) achieved an intermediate effect ( Fig. 4c, d ). Expression of shRNAs per se did not affect cell growth (Fig. 4d) . Similarly, silencing of p16 INK4a by either expression of shRNA (shp16 INK4a ) or its suppressor Bmi-1 (ref. 37 ) partially restored CCN1-induced growth suppression (by <60%; Fig. 4e-f ). These results show that the p53 and p16 INK4a /pRb pathways both contribute to CCN1-induced senescence.
CCN1 induces senescence through α 6 β 1 integrin-dependent ROS generation by activation of NOX1 Next, we assessed the role of ROS, as its accumulation can induce senescence 36, 38 and CCN1 is known to induce ROS accumulation 28, 29 . Pretreatment of cells with NAC abrogated CCN1-induced senescence ( Fig. 5a, b) , indicating a requirement for ROS. CCN1-induced ROS accumulation is mediated through α 6 β 1 integrin, as it was lost in cells pretreated with anti-α 6 antibody but not with anti-α v β 3 integrin antibody ( Fig. 5c ). As cell adhesion can generate ROS 39 , we compared accumulation of ROS after cell adhesion to CCN1 and other ECM proteins to assess how CCN1 uniquely triggers senescence. Cell adhesion to fibronectin, laminin, vitronectin and type I collagen transiently induced a low level of ROS that returned to background levels by 4 h in most cases, whereas cell adhesion to CCN1 induced a higher level of ROS that was sustained for at least 4 h ( Fig. 5d ). Moreover, addition of NAC 3-6 h post-CCN1 treatment completely blocked senescence, whereas NAC added 10 and 24 h post-CCN1 treatment was partially and completely ineffective, respectively ( Fig. 5e ). Thus, CCN1 induces a high level of ROS that must be sustained for least 6-10 h for the establishment of senescence. NADPH oxidases (NOXs) and 5-lipoxygenase (5-LOX) participate in ROS generation downstream of ECM-integrin interactions 28, 39 . The NOX inhibitor apocynin blocked CCN1-induced senescence whereas the 5-LOX inhibitor MK886 did not, suggesting that NOX, but not 5-LOX, might be responsible for ROS necessary for senescence ( Fig. 6a ). Consistently, shRNAs (sh5LOX #2) that completely silenced 5-LOX expression had no effect on CCN1-induced proliferation arrest (Fig. 6b ). Among the five NOX isoforms, NOX1 and NOX4 are widely expressed in non-phagocytic cells including fibroblasts 40 . (e) Cells were pre-incubated with function-blocking antibodies (50 μg ml -1 ) against α v β 3 integrin (LM609) or α 6 (GoH3), and assayed for SA-β-gal. (f) Soluble heparin (1 mg ml -1 ) was added 1 h before CCN1 treatment, and SA-β-gal assayed and compared with vehicle control (PBS). Experiments were done in triplicate and data presented as means ± s.d. (g) Cells were treated with CCN1 (BSA control) and with either the α 6 β 1 integrin-binding T1 peptide or the non-binding mutant (mut-T1; 0.5 mM each) 27,33 as a competitor, before quantifying the number of SA-β-gal-positive cells. Experiments were done in triplicate and data presented as means ± s.d.
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CCN1 upregulated NOX1 expression in BJ cells whereas NOX4 and catalase expression was unaffected ( Fig. 6c ), suggesting that NOX1 may be critical. Knockdown of NOX1 by either of two shRNAs (#1 and #2) partially bypassed CCN1-induced growth arrest, whereas knockdown of NOX4 had no effect (Fig. 6d ). Furthermore, RAC1 is required for NOX1 activation, especially when cellular levels of the co-activating proteins NOXO1 and NOXA1 are low, but is dispensable for NOX4 activity 40 . RAC1 is activated by CCN1-induced adhesive signalling through α 6 β 1 integrin-HSPGs 41 . Depletion of RAC1 by shRNA rescued cells from CCN1-induced growth arrest, consistent with the requirement for NOX1 ( Fig. 6e ). Thus, CCN1 induces the expression of NOX1 and its activation through RAC1, thereby activating the superoxidegenerating RAC1-NOX1 complex required for CCN1-induced senescence. Consistently, the accumulation of superoxides in healing wounds is inhibited in Ccn1 dm/dm mice, indicating its dependence on CCN1 (Supplementary information, Fig. S3b ).
Induction of p16 INK4a through ROS-dependent activation of ERK and p38 MAPK
The induction of p16 INK4a is regulated by mitogenic and stress-response pathways, including the extracellular signal-regulated kinase (ERK; p42/ p44) and p38 mitogen-activated protein kinase (MAPK) 42, 43 . Both ERK and p38 MAPK, but not JNK, were activated by phosphorylation in a biphasic manner on CCN1 treatment ( Fig. 7a ; Supplementary information, Fig. S3d ). The first activation phase occurred within 3 h of CCN1 treatment, followed by inactivation and reactivation in the second phase by 24 h. Pretreatment of cells with inhibitors of p38 MAPK (SB202190) or the ERK-activating kinase MEK1 (PD98059) blocked CCN1-induced SA-β-gal expression, whereas the JNK inhibitor SP600126 had little effect (Fig. 7b ). Moreover, both SB202190 and PD98059 abrogated CCN1-induced p16 INK4a expression, but SP600126 had no effect ( Fig. 7c and data not shown). These results show that ERK and p38 MAPK, but not JNK, are required for CCN1-mediated induction of p16 INK4a , which is critical for senescence. ROS can activate stress-activated kinases such as MAPKs through activation of the redox-sensitive ASK1 (apoptosis signal-regulating kinase 1; ref. 44 ). Furthermore, ROS can sustain MAPK activation by neutralizing MAPK phosphatases through oxidative inactivation of the cysteine residue at their active sites 45 . Therefore, we tested whether CCN1-induced ERK and p38 MAPK activation is ROS-dependent ( Fig. 7d ). Both kinases were activated by CCN1 in a biphasic manner (3 h and 24 h), and apocynin effectively abrogated ERK and p38 MAPK activation at both early and late phases. NAC also blocked ERK activation at both times, and inhibited late activation of p38 MAPK. Together, these results show that CCN1-induced ROS generation leads to the activation of ERK and p38 MAPK, triggering p16 INK4a induction and cellular senescence (Fig. 7e ).
CCN1-regulated senescence restricts fibrosis in cutaneous wound healing
The fibrogenic response contributes to tissue repair by helping to reconstitute the damaged tissue through ECM deposition, although excessive fibrosis may impair tissue function 24, 46 . Senescent cells express an antifibrotic genetic programme and may thus protect against excessive fibrosis during wound healing 2, 15 . To test whether CCN1-induced senescence regulates fibrosis in vivo, we quantified the expression of genes relevant to fibrosis in wound tissues. Granulation tissue of wildtype mice expressed much higher levels of Mmp2, Mmp3 and Mmp9 than Ccn1 dm/dm mice (Fig. 8a) . Ccn1 dm/dm wounds lacked senescent cell accumulation and expressed a higher level of Col1a1 and the fibrotic mediator, Tgfb1, indicating an enhanced fibrotic response (Figs 1e and  8b ). Collagen deposition, as measured by hydroxyproline content, was significantly higher in Ccn1 dm/dm wounds, a difference that persisted at least 21 days post-wounding, much later than the completion of wound closure (Fig. 8c ). Staining of granulation tissues with Sirius red revealed a substantial increase in collagen in Ccn1 dm/dm wounds under polarized light (Fig. 8d, e ). To assess the role of CCN1 in wound healing directly, we treated excisional cutaneous wounds in Ccn1 dm/dm mice with topical applications of purified CCN1 protein or buffered saline. Addition of CCN1 reversed the profibrotic phenotype of Ccn1 dm/dm mice, resulting in significantly enhanced expression of Mmp2, Mmp3 and Mmp9, reduced expression of Col1a1 and Tgfb1, and curtailed collagen deposition as detected by Sirius-red staining (Fig. 8f, g) . Furthermore, application of CCN1 protein induced cellular senescence in cutaneous wounds in senescence-deficient Ccn1 dm/dm mice (Fig. 8h ). Together, these results show that CCN1 induces cellular senescence in granulation tissue and curbs the fibrogenic response during cutaneous wound healing.
DISCUSSION
We show here that the matricellular protein CCN1 induces fibroblast senescence through an integrin-mediated mechanism, resulting in the expression of antifibrotic genes to dampen fibrosis in cutaneous wound healing. Rapid synthesis of ECM occurs in wound repair to provide structural integrity to damaged tissues, although excessive matrix deposition can lead to fibrosis and scarring where ECM replaces parenchyma, resulting in loss of tissue function 24, 46 . Fibrosis commonly occurs as the result of a persistent wound-healing response to chronic injuries in many mammalian organs; for example in the liver (in response to viral infections, alcoholism and non-alcoholic fatty liver disease) and the heart (after myocardial infarctions) 23, 46 . As the wound-healing process in most mammalian organs is remarkably similar irrespective of the underlying etiology 24 , our data from cutaneous wound healing may be informative nature cell biology VOLUME 12 | NUMBER 7 | JULY 2010 6 8 1
to wound repair more generally. Indeed, our findings concur with those of recent studies showing that senescent hepatic stellate cells accumulate in CCl 4 -induced liver injury to limit fibrosis 15 . Together, they support the idea that cellular senescence may occur as a general, programmed wound-healing response that functions in disparate organ systems to control fibrosis. Thus, although cellular senescence has an established role in tumour suppression, its contribution to the biology of wound healing and tissue repair is beginning to emerge. Ccn1 was first identified as an immediate-early gene that is inducible by serum growth factors in fibroblasts 47 . Although serum was initially thought to induce a genetic programme for cell proliferation, later genomic analyses indicated that a subset of serum-inducible genes represented a wound-healing response 48 . Consistently, Ccn1 is highly expressed at sites of wound healing in various tissues, including cutaneous, cardiovascular and bone injuries 18 . Here, we provide direct evidence that CCN1 has a critical function in cutaneous wound healing by its induction of fibroblast senescence and expression of antifibrotic genes. Topical treatment of wounds with purified CCN1 reversed the enhanced fibrogenesis suffered by mice lacking senescence-competent CCN1 (Fig. 8) . These findings establish the functions of CCN1 in cutaneous wounds and suggest that exogenous delivery of CCN1 or induction of CCN1 signalling may have therapeutic value for the treatment of fibrosis associated with wound healing. The specific triggers that activate Ccn1 expression during wound healing are as yet unknown, although the Ccn1 promoter is responsive to a wide spectrum of inducing signals 47, 49 . Interestingly, a related member of the CCN family, CCN2, mediates profibrotic responses in diverse pathologies 50, 51 . Thus, CCN1 and CCN2 may regulate the fibrogenic process during wound healing in disparate and possibly opposing ways. CCN1 induces cellular senescence by binding to its receptors that are involved in cell adhesion, α 6 β 1 integrin and cell-surface HSPGs, to engage both p53-and p16 INK4a -dependent senescence pathways. Mice nullizygous for p53 and INK4a/ARF are deficient in senescent cell accumulation in CCl 4 -induced liver injury 15 , suggesting that cellular senescence may occur through similar pathways in diverse models of wound healing. Mechanistically, CCN1 triggers senescence by activating p53 through induction of a DNA damage response pathway, and in part through a ROSdependent pathway ( Fig. 4b and Supplementary Information, Fig. S3a ). CCN1 also induces ROS generation through the RAC1-NOX1 complex and ROS-dependent biphasic activation of ERK and p38 MAPK, leading to induction of the p16 INK4a /pRb pathway (Fig. 7e ). Although the cell adhesion process generates ROS, CCN1 is unique among ECM proteins as a cell-adhesive substrate in triggering a robust and sustained accumulation of ROS necessary for senescence. Whereas CCN1 can induce ROS generation through multiple mechanisms 28, 29 , distinct cellular sources of ROS may participate in disparate biological functions with specificity. For example, apoptotic synergism between CCN1 and TNFα (tumour necrosis factor α) requires ROS generated through 5-LOX but not NOX 28 , whereas CCN1induced senescence requires NOX1 but not 5-LOX (Fig. 6 ). The specific nature, kinetics and/or subcellular localization of ROS generated by distinct cellular sources may contribute to their functional specificity 52 . Whether CCN1 is required for cellular senescence in disparate organ systems and in broader biological contexts beyond wound repair is currently unknown. However, it is noteworthy that CCN1 expression is elevated in several human pathologies associated with the occurrence of senescent cells, including atherosclerotic plaques, benign prostatic hyperplasia and chronologically aged human skin [53] [54] [55] [56] . These results suggest that CCN1 may contribute to senescence in certain age-related diseases and conditions. Both cellular senescence and apoptosis function in tumour suppression 2, 17 , and CCN1 can synergize with TNFα and related cytokines to trigger robust apoptosis in vitro and in vivo 28, 29, 57 suggesting that CCN1 may function as a tumour suppressor by inducing apoptosis and/or senescence. Indeed, several studies have suggested that CCN1 may suppress tumorigenesis [58] [59] [60] [61] . Paradoxically, CCN1 is also a potent angiogenic inducer and may promote tumour growth 18, 19 . Thus, the role of CCN1 in tumorigenesis may be cell type-and context-dependent, and may hinge on whether angiogenic factors are limiting, or whether conditions conducive for apoptosis or senescence prevail. Defining the roles of CCN1-induced senescence in diverse models of wound healing, ageing-related pathologies and tumorigenesis clearly merits further investigation.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/ After washing five times in PBST, the slides were incubated with the secondary antibody mix (TRITC-conjugated anti-mouse IgG and FITC-conjugated antirabbit IgG for p53; TRITC-conjugated anti-rabbit IgG and FITC-conjugated anti-mouse IgG for p16) for 30 min, followed by washing five times in PBST. DAPI (1 μg ml -1 ) was used for counterstaining. The fluorescence images were acquired using with a Zeiss Axiovert 200 M microscope and processed with Photoshop 7 (Adobe).
Isolation of cells from wounds and measurement of collagen deposition in wounds.
Cells were isolated from 7-and 9-day wounds (n = 3) as described 68 and plated in 60 mm culture dishes. For hydrxoyproline assay, skin wounds (n = 3 for both genotypes) were harvested at indicated days and dried in a 110 °C oven overnight, placed in a screw-capped glass vessel and hydrolysed in 6 N hydrochloric acid at 110 °C for 18 h. The lysates were processed and hydroxyproline content determined as described 69 , using purified hydroxyproline to generate a standard curve. Alternatively, frozen section of wound tissues were processed for Sirius-red staining (Sigma) and viewed under polarized light. The Sirius-red-positive area was calculated using ImageJ software (NIH).
Statistics.
Results are expressed as the mean ± s.d. and statistical analysis was performed by one-way ANOVA analysis of variance and Student's t-test. A P < 0.05 was considered significant.
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Figure S1 CCN1 expression and senescent cells accumulation in granulation tissues. (a) Frozen sections from WT and Ccn1 dm/dm mice (n=3 each) 7 days post wounding were subjected to immunohistochemistry (IHC) for CCN1 using DAB as chromogen and counterstained with Hematoxylin. No apparent difference was found between WT and Ccn1 dm/ dm mice in CCN1 staining (brown), which occurred predominantly in the granulation tissue. Scale bar = 100 μm. (b) SA-β-gal staining was performed on frozen sections from WT and Ccn1 dm/dm mice 7 and 9 days post-wounding, followed by Eosin counterstaining. High magnification images (20× and 40×) clearly show the accumulation of senescent cells in the WT granulation tissue. Low magnification images (5×) show the entire wound area; boxes marked the enlarged areas. Scale bar = 50 μm. (c) Wound sections were double-stained with p53 (red) and α-SMA (green) and counterstained with DAPI (blue). Arrowheads point to isolated cells with nuclear staining of p53, and the surrounding cytoplasm stained positive for α-SMA.
Figure S3
ROS signaling in CCN1-induced senescence. (a) NAC partially inhibits p53 phosphorylation. BJ cells were treated with CCN1 for indicated days either in the presence or absence of NAC (2.5 mM). Western blot analysis was performed to detect p53 phosphorylation at Ser-20. β-actin was used for loading control. n.s. indicates a non-specific band. (b) Superoxide generation in cutaneous wounds. Superoxide was measured from wound tissues of WT and Ccn1 dm/dm mice 5-9 days post-wounding by lucigeninbased chemiluminescence, and compared to unwounded skin control. (n=4) (c) BJ cells were treated with fresh full-growth medium with BSA for indicated time periods, or with medium and CCN1 for 24 hrs. Western blot analysis was performed for p-ERK and total ERK, and p-p38 MAPK and total p38 MAPK.
Figure S4
Full scans of Western blots. Supplementary Table II 
